Viatris Inc
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and … Read more
Viatris Inc (VTRS) - Total Liabilities
Latest total liabilities as of September 2025: $22.70 Billion USD
Based on the latest financial reports, Viatris Inc (VTRS) has total liabilities worth $22.70 Billion USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Viatris Inc - Total Liabilities Trend (1985–2024)
This chart illustrates how Viatris Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Viatris Inc Competitors by Total Liabilities
The table below lists competitors of Viatris Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
H4W0
F:H4W0
|
Germany | €31.74 Billion |
|
Emera Incorporated
NYSE:EMA
|
USA | $31.40 Billion |
|
Teva Pharmaceutical Industries Limited
PINK:TEVJF
|
USA | $32.84 Billion |
|
Corem Property Group AB (publ)
ST:CORE-D
|
Sweden | Skr36.64 Billion |
|
FinecoBank Banca Fineco S.p.A
PINK:FNBKY
|
USA | $33.11 Billion |
|
Magna International Inc
NYSE:MGA
|
USA | $19.95 Billion |
|
Super Micro Computer Inc
NASDAQ:SMCI
|
USA | $21.01 Billion |
Liability Composition Analysis (1985–2024)
This chart breaks down Viatris Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.35 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.49 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.60 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Viatris Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Viatris Inc (1985–2024)
The table below shows the annual total liabilities of Viatris Inc from 1985 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $22.87 Billion | -15.99% |
| 2023-12-31 | $27.22 Billion | -5.98% |
| 2022-12-31 | $28.95 Billion | -15.72% |
| 2021-12-31 | $34.35 Billion | -11.01% |
| 2020-12-31 | $38.60 Billion | +99.25% |
| 2019-12-31 | $19.37 Billion | -5.82% |
| 2018-12-31 | $20.57 Billion | -8.58% |
| 2017-12-31 | $22.50 Billion | -4.70% |
| 2016-12-31 | $23.61 Billion | +88.84% |
| 2015-12-31 | $12.50 Billion | -0.34% |
| 2014-12-31 | $12.54 Billion | +1.70% |
| 2013-12-31 | $12.33 Billion | +43.83% |
| 2012-12-31 | $8.58 Billion | +5.96% |
| 2011-12-31 | $8.09 Billion | +2.17% |
| 2010-12-31 | $7.92 Billion | +3.46% |
| 2009-12-31 | $7.66 Billion | +0.66% |
| 2008-12-31 | $7.61 Billion | -3.90% |
| 2007-12-31 | $7.92 Billion | +208.98% |
| 2006-12-31 | $2.56 Billion | +136.57% |
| 2005-12-31 | $1.08 Billion | +273.74% |
| 2004-12-31 | $289.74 Million | +28.62% |
| 2003-12-31 | $225.27 Million | -24.63% |
| 2002-12-31 | $298.89 Million | +39.36% |
| 2001-12-31 | $214.47 Million | -35.68% |
| 2000-12-31 | $333.44 Million | +142.49% |
| 1999-12-31 | $137.51 Million | -6.33% |
| 1998-12-31 | $146.80 Million | +42.11% |
| 1997-12-31 | $103.30 Million | -12.38% |
| 1996-12-31 | $117.90 Million | +55.95% |
| 1995-12-31 | $75.60 Million | +19.06% |
| 1994-12-31 | $63.50 Million | +172.53% |
| 1993-12-31 | $23.30 Million | -57.71% |
| 1992-12-31 | $55.10 Million | +137.50% |
| 1991-12-31 | $23.20 Million | +42.33% |
| 1990-12-31 | $16.30 Million | +58.25% |
| 1989-12-31 | $10.30 Million | +22.62% |
| 1988-12-31 | $8.40 Million | -56.02% |
| 1987-12-31 | $19.10 Million | +55.28% |
| 1986-12-31 | $12.30 Million | +44.71% |
| 1985-12-31 | $8.50 Million | -- |